Nicotinamide riboside

Also called NR

Nicotinamide riboside has been studied in 650 papers since 1987: 67 trials and 16 observational studies in people, 316 in animals, 93 in cells, 133 reviews; 129 in the past year. The newest story, Nov 9, 2026: “High-fat diet triggers irregular heart rhythms in altered mice”.

InterventionNAD+ precursors

650 papers study it26 more mention it1,271 findingsUpdated

PubChemChEBI

Research on it is growing 17% faster than aging research as a whole: 18 papers in the latest year counted

More supplements

20 new papers in 30 daysSee all 640 papers on nicotinamide riboside

At a glance

Nicotinamide riboside extends yeast lifespan across independent labs; human trials report increased blood NAD+ but no clear cognitive effect. Mouse inflammation results point both ways. There are 33 registered aging trials; across all uses, 12 trials ended over a year ago without posted results, while 13 of 57 human papers declare ties to developers Niagen Bioscience and Elysium Health.

1,271 findings in 432 papers from 1989 to 2026, 49 of them since April 2026

Independent labs found the same change in cells, worms or flies, mice and people. 172 independent labs in 34 countries; 75 trials, 37 about aging, 12 with no results posted.

“yielding an adjusted mean difference of 2.72 points (95% CI, 0.47-4.98 points; P = .02), favoring placebo.”
Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical TrialJAMA2026doi:10.1001/jama.2026.18828

58 of its findings point the other way.

Cells, worms or flies, mice and humans: replicated by independent labs.
  • 172 independent labs in 34 countries
  • 58 findings against
  • 75 trials, 37 about aging, 12 with no results posted
  • Funders: National Institutes of Health and others
  • 182 of 1,200 findings with company ties
  • 17 of 75 trials sponsored by its developers
  • Human trial65
  • Humans16
  • Animals298
  • Model organisms7
  • Cells82
  • In silico2

47 studies gave nicotinamide riboside to people and measured what changed.

What changedDesignPeopleSource

up: Improves clinical performance

Treated cohort4 peopleyoung adultsMTFMT deficiencyMolecular genetics and metabolism, Nov 1, 2026

no change: Has no effect on NAD+

up: Increases MitoATP/GlycoATP ratio

down: Decreases urinary lipid oxidation markers

Trialapproximately 90 daysSelf-administered subcutaneous injectionsmedRxiv, Oct 15, 2026

up: Increases NAD+9.5, 8.8, 11.1, and 15.1% average increases

Randomized trialthree consecutive days39 peopleFemale participants represented 59% of the study population46.7 (±1.9 SEM)Generally healthy adults with baseline fatiguemedRxiv, Oct 14, 2026

up: Increases MDS-UPDRS total scoreAdjusted mean difference 2.72 points (95% CI, 0.47–4.98), favoring placebo

up: Increases Non-Motor Symptoms Scale scoreAdjusted mean difference 4.22 points (95% CI, 1.07–7.37)

Randomized trial52 weeks393 peopleBothMean 65.6 (SD, 9.4) yearsMidlife adults; Older adults; Early Parkinson diseaseJAMA, Oct 8, 2026

down: Decreases MEAT-derived epigenetic age accelerationß = −2.39

down: Decreases DunedinPACEß = −0.04

Trial5 months36 peoplefemale participants comprised 44%–48%30–65 yearsMonozygotic twin pairs discordant for body mass indexAging cell, Jul 22, 2026

What did mouse lifespan tests of nicotinamide riboside find?

NIA ITP

The NIA Interventions Testing Program ran 1 arm in 2016; the change in median lifespan ran from −3% to 0%.

What did other lifespan studies of nicotinamide riboside find?

DrugAge

DrugAge records 2 results from 2 papers: 1 in mice and 1 in S. cerevisiae. Average lifespan is the mean or the median, as each paper reports it.

What did studies of nicotinamide riboside find?

545

Studies of nicotinamide riboside measured 545 outcomes; the most studied are NAD+ (51 studies), inflammation (26) and oxidative stress and ROS signaling (17).

NAD+

upin mice18upin humans13upin reviews8upin rats5+6

51 studies
  1. Nicotinamide riboside showed no clear effect on NAD+ in humans (self-administered subcutaneous injections).

    “Whole-blood NAD+ concentrations remained largely stable over time in both dose groups.”

    Human trialself-administered subcutaneous injectionspharmaceutical-gradewhole blood50 or 100 mg, 3 times weeklyapproximately 90 days

    Part 2 of a 2-part open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 90 days of at-home subcutaneous injections

    medRxivPreprint

  2. Nicotinamide riboside increases NAD+ in humans following the first injection (9.5, 8.8, 11.1, and 15.1% average increases).

    “A total of 38/39 participants demonstrated an increase in NAD+ during at least one time point assessed following the first injection, resulting in 9.5, 8.8, 11.1, and 15.1% average increases in the 50 mg IM, 50 mg SC, 100 mg IM, and 100 mg SC groups, respectively.”

    Human trialfollowing the first injectionthree consecutive daysn = 39

    Part 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injections

    medRxivPreprint

  3. Nicotinamide riboside increases NAD+ in humans (Intramuscular or subcutaneous administration; no placebo group) (Average daily increases: 9.51% (50 mg IM), 9.97% (100 mg IM), 7.83% (50 mg SC), 9.05% (100 mg SC)).

    “an average of the daily percentage increases in NAD+ was consistent across treatment groups”

    Human trialIntramuscular or subcutaneous administration; no placebo grouppharmaceutical-grade injectable NRwhole blood50 or 100 mg daily3 consecutive daysn = 39

    Part 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injections

    medRxivPreprint

  4. Nicotinamide riboside increases NAD+ in humans (twofold).

    “Consistent with prior studies of NR supplementation reporting an increase in NAD+ metabolites or catabolites,,,,, we observed a robust increase in blood NAD+ concentration in the NR group compared to placebo, with levels nearly doubling from baseline.”

    Human trialblood12‐weekn = 52

    Nicotinamide riboside did not improve cognition in a 12-week trial

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  5. Nicotinamide riboside increases NAD+ in humans.

    “In the pooled cohort, blood NAD levels increased significantly over time during treatment (LME, p = 1.30x10−9) and a decline during washout (LME, p = 6.51x10−13).”

    Human trialblood4 weeksn = 12

    The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation

    iScience

  6. Nicotinamide riboside increases NAD+ in humans (NAD+ 23.36 to 48.52 μM with NR vs 24.12 to 25.14 μM with placebo; treatment by time interaction p<0.001).

    “Blood NAD + increased with NR (pre: 23.36 ± 1.94; post: 48.52 ± 4.12 μM) compared with placebo”

    Human trialblood500 mg b.i.d.12-week

    A phase‐II randomized controlled pilot and feasibility study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment

    AAIC 2025 abstract

  7. Nicotinamide riboside increases NAD+ in humans (NR-NR group, within-group change over 5-10 weeks of NR) (2.6- to 3.1-fold).

    “In the NR-NR group, NAD+ levels increased by 2.6- to 3.1-fold after 5-10 weeks of supplementation”

    Human trialNR-NR group, within-group change over 5-10 weeks of NR2000 mg/day5-10 weeks

    Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

    EClinicalMedicine

  8. Nicotinamide riboside increases NAD+ in humans (more than twofold).

    “NR treatment increased NAD+ levels by more than twofold in whole blood”

    Human trialwhole blood

    Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial

    Nature aging

  9. Nicotinamide riboside increases NAD+ in humans (71.1 μM (95% CI 57.2–85.0 μM) vs no change).

    “Six weeks of oral supplementation with NR increased NAD+ levels in whole blood by 71.1 μM (95% CI 57.2–85.0 μM) in patients with COPD and by 49.4 μM (95% CI 30.9–68.0 μM) in lung-healthy controls, with no change for placebo.”

    Human trial6 weeks

    Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial

    Nature aging

  10. Nicotinamide riboside increases NAD+ in humans (0.065 mM (~16%) higher).

    “On average, cerebral NAD+ levels were 0.065 mM (~16%) higher after taking the NR supplement, which was significant compared to baseline (t(8)=5.93, p<0.001).”

    Human trialbrainfour hoursn = 9

    Acute nicotinamide riboside supplementation increases human cerebral NAD⁺ levels in vivo

    Magnetic resonance in medicine

All 54

More on NAD+

Inflammation

downin mice17downin rats2downin humans1downin M. amblycephala cells1+5

26 studies
  1. Nicotinamide riboside decreases inflammation in mice (myocardial infarction).

    “Mechanistically, NR protection converged on the SIRT1–p65 axis, limiting ferroptotic and inflammatory injury while preserving mitochondrial function.”

    Animalsmyocardial infarctionhydrogel-mediated deliveryheart

    Localized Nicotinamide Riboside Delivery Through a Reversible Affinity Hydrogel Promotes Myocardial Restoration

    Advanced Functional Materials

  2. Nicotinamide riboside decreases inflammation in mice (heat exposure).

    “This effect is associated with anti-inflammatory and antioxidative activities, mitochondrial protection, and anti-apoptosis without NAD+ homeostatic alterations.”

    Animalsheat exposureskeletal muscle185 mg/kg body weight daily10 daysfemales

    Nicotinamide Riboside Supplementation Protects Against Heat-Induced Skeletal Muscle Injury in Female Mice

    Muscles (Basel, Switzerland)

  3. Nicotinamide riboside decreases inflammation in db/db mice.

    “NR attenuated markers of inflammation, including astrocytosis and microglial activation, activation of inflammatory signaling via STING and NF-kB, and pro-inflammatory cytokines.”

    Animalsin db/db micehippocampus500 mg/kg20 weeks

    Nicotinamide Riboside (NR) Supplementation Exerts Neuroprotective Effects in db/db Mouse Model of Type 2 Diabetes

    Journal of molecular neuroscience : MN

  4. Nicotinamide riboside decreases inflammation in APP/PS1 mice.

    “NR treatment restored mitochondrial integrity, suppressed cGAS-STING signaling, and reduced neuroinflammation, improving vascular function and cognition.”

    Animalsin APP/PS1 mice

    Endothelial NAD⁺ depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  5. Nicotinamide riboside decreases inflammation in 5xFAD mice.

    “Interestingly, NR restores glutamate homeostasis and alleviates neuroinflammatory processes, thus rescuing tissue from excitotoxic insults.”

    Animalsin 5xFAD mice

    In vivo imaging of glutamate uncovers the neuroprotective effects of nicotinamide riboside on excitotoxicity in an Alzheimer's mouse model

    Alzheimer's research & therapy

  6. Nicotinamide riboside decreases inflammation in mice (pretreatment in aged mice after ischemic stroke; systemic and brain inflammation).

    “reduced systemic and brain inflammation, and improved stroke outcomes in aged mice.”

    Animalspretreatment in aged mice after ischemic stroke; systemic and brain inflammation

    NAD⁺ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside

    Journal of neuroinflammation

  7. Nicotinamide riboside decreases inflammation in mice (aged mice compared with untreated aged controls).

    “Gene expression profiling revealed reduced microglial activation, inflammatory pathways, and chemokine production in Aged + NR mice”

    Animalsaged mice compared with untreated aged controlsmicroglia400 mg/kg body weight8 weeks

    Nicotinamide riboside supplementation restores microglial health and improves cognition in aged male mice

    GeroScience

  8. Nicotinamide riboside decreases inflammation in mice (combined with hypoxia exposure).

    “lowered the interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), and inducible nitric oxide synthase (iNOS) mRNA levels”

    Animalscombined with hypoxia exposure

    Nicotinamide Riboside Alleviates the Neurotoxic Injury of Dendritic Spine Plasticity Mediated by Hypoxic Microglial Activation

    Biomolecules

  9. Nicotinamide riboside decreases inflammation in pigs (induced by heat stress).

    “attenuated oxidative stress and inflammation induced by HS”

    Animalsinduced by heat stresstestismales

    Nicotinamide Riboside Supplementation Alleviates Heat Stress-Induced Testicular Damage and Improves Semen Quality in Boars

    Molecular nutrition & food research

  10. Nicotinamide riboside decreases inflammation in mice (heat exposure).

    “The protective effect of NR on mouse intestinal barrier against heat is associated with reduced inflammation and oxidative stress.”

    Animalsheat exposureintestine10 daysmales

    Nicotinamide Riboside Alleviates Heat Stress-induced Intestinal Barrier Dysfunction in Mice

    Shock (Augusta, Ga.)

All 26

More on Inflammation

Oxidative stress and ROS signaling

downin mice7downin human cells2downin mouse cells2downin rats2+4

17 studies
  1. Nicotinamide riboside decreases oxidative stress and ROS signaling in mice (heat exposure).

    “This effect is associated with anti-inflammatory and antioxidative activities, mitochondrial protection, and anti-apoptosis without NAD+ homeostatic alterations.”

    Animalsheat exposureskeletal muscle185 mg/kg body weight daily10 daysfemales

    Nicotinamide Riboside Supplementation Protects Against Heat-Induced Skeletal Muscle Injury in Female Mice

    Muscles (Basel, Switzerland)

  2. Nicotinamide riboside prevents oxidative stress and ROS signaling in mouse cells (palmitic acid-exposed proximal tubular epithelial cells).

    “NR significantly prevented oxidative stress in proximal tubular epithelial cells”

    Cellspalmitic acid-exposed proximal tubular epithelial cells

    Effects of NAD⁺ repletion with Nicotinamide riboside on obesity-induced chronic kidney disease and renal cell lipotoxicity

    Scientific reports

  3. Nicotinamide riboside decreases oxidative stress and ROS signaling in pigs (induced by heat stress).

    “attenuated oxidative stress and inflammation induced by HS”

    Animalsinduced by heat stresstestismales

    Nicotinamide Riboside Supplementation Alleviates Heat Stress-Induced Testicular Damage and Improves Semen Quality in Boars

    Molecular nutrition & food research

  4. Nicotinamide riboside decreases oxidative stress and ROS signaling in endothelial cells treated with patient sera.

    “NAD+ supplementation with NR was associated with reduced oxidative stress and increased nitric oxide production and mitochondrial efficiency in endothelial cells treated with patient sera.”

    Cellsin endothelial cells treated with patient seracerebromicrovascular endothelial cells4 weeks

    Effects of NAD⁺ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial

    The Journal of pharmacology and experimental therapeutics

  5. Nicotinamide riboside decreases oxidative stress and ROS signaling in mice (heat exposure).

    “The protective effect of NR on mouse intestinal barrier against heat is associated with reduced inflammation and oxidative stress.”

    Animalsheat exposureintestine10 daysmales

    Nicotinamide Riboside Alleviates Heat Stress-induced Intestinal Barrier Dysfunction in Mice

    Shock (Augusta, Ga.)

  6. Nicotinamide riboside decreases oxidative stress and ROS signaling in human cells (doxorubicin-induced cardiotoxicity).

    “reduces cardiomyocyte oxidative stress injury, and attenuates apoptosis”

    Cellsdoxorubicin-induced cardiotoxicity

    Nicotinamide riboside promoted cardiac energetics and alleviated doxorubicin-induced cardiotoxicity via SIRT1/ERRα signal in human pluripotent stem cells-derived cardiomyocytes

    Life sciences

  7. Nicotinamide riboside decreases oxidative stress and ROS signaling in mouse cells (ethanol-induced).

    “Our findings demonstrate the ability of NR to alleviate ethanol-induced oxidative stress, inflammation, and mitochondrial dysfunction”

    Cellsethanol-inducedimmortalized mouse Kupffer cells

    Nicotinamide riboside targets mitochondrial unfolded protein response to reduce alcohol-induced damage in Kupffer cells

    The Journal of pathology

  8. Nicotinamide riboside decreases oxidative stress and ROS signaling in cells (glutamate-induced excitotoxicity in R28 cells).

    “it significantly attenuated oxidative stress induced by glutamate”

    Cellsglutamate-induced excitotoxicity in R28 cells

    The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model

    Experimental eye research

  9. Nicotinamide riboside decreases oxidative stress and ROS signaling in rats (LPS-induced rat model of inflammation-driven PE).

    “improved placental mitochondrial function, and reduced inflammation and oxidative stress”

    AnimalsLPS-induced rat model of inflammation-driven PEplacenta200 mg/kg/daygestational days 1-19females

    NAD⁺ depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia

    Life science alliance

  10. Nicotinamide riboside decreases oxidative stress and ROS signaling in mice after 6.0 Gy γ-ray total body irradiation.

    “NR can mitigate oxidative damage”

    Animalsafter 6.0 Gy γ-ray total body irradiationintestine400 mg/kg/d21 daysmales

    Nicotinamide riboside alleviates ionizing radiation-induced intestinal senescence by alleviating oxidative damage and regulating intestinal metabolism

    Journal of advanced research

All 17

More on Oxidative stress and ROS signaling

Apoptosis

downin mice5downin cells3downin human cells2downin mouse cells2+3

15 studies
  1. Nicotinamide riboside decreases apoptosis in mice (heat exposure).

    “This effect is associated with anti-inflammatory and antioxidative activities, mitochondrial protection, and anti-apoptosis without NAD+ homeostatic alterations.”

    Animalsheat exposureskeletal muscle185 mg/kg body weight daily10 daysfemales

    Nicotinamide Riboside Supplementation Protects Against Heat-Induced Skeletal Muscle Injury in Female Mice

    Muscles (Basel, Switzerland)

  2. Nicotinamide riboside decreases apoptosis in human cells (doxorubicin-induced cardiotoxicity).

    “reduces cardiomyocyte oxidative stress injury, and attenuates apoptosis”

    Cellsdoxorubicin-induced cardiotoxicity

    Nicotinamide riboside promoted cardiac energetics and alleviated doxorubicin-induced cardiotoxicity via SIRT1/ERRα signal in human pluripotent stem cells-derived cardiomyocytes

    Life sciences

  3. Nicotinamide riboside decreases apoptosis in cells.

    “apoptosis of CD8+ T cells was reduced after NR treatment”

    Cells

    Effect of Nicotinamide Riboside Against the Exhaustion of CD8⁺ T Cells via Alleviating Mitochondrial Dysfunction

    Nutrients

  4. Nicotinamide riboside decreases apoptosis in cells (glutamate-induced excitotoxicity in R28 cells).

    “effectively inhibit the apoptosis of R28 cells induced by glutamate”

    Cellsglutamate-induced excitotoxicity in R28 cells

    The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model

    Experimental eye research

  5. Nicotinamide riboside induces apoptosis in human cells (3D BEAS-2B cell spheroid culture).

    “all concentrations tested in the 3D cell culture model (BEAS-2B cell spheroids exposed to 1, 5, 10, and 50 μM NR) induced apoptosis”

    Cells3D BEAS-2B cell spheroid culture1, 5, 10 and 50 μM

    Nicotinamide riboside Induced Energy Stress and Metabolic Reprogramming in BEAS-2B Cells

    Chemical research in toxicology

  6. Nicotinamide riboside decreases apoptosis in rats (myocardial I/R injury).

    “mitigating mitochondrial damage and inhibiting apoptosis during myocardial I/R injury”

    Animalsmyocardial I/R injurymyocardium

    Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  7. Nicotinamide riboside decreases apoptosis in M. amblycephala cells (high-glucose-treated hepatocytes, compared with NA, NAM and NMN).

    “NR presented distinct and superior effects in terms of anti-oxidative stress, inflammation inhibition, and anti-apoptosis compared with NA, NAM, and NMN.”

    Cellshigh-glucose-treated hepatocytes, compared with NA, NAM and NMNhepatocytes

    The Effectiveness of Four Nicotinamide Adenine Dinucleotide (NAD⁺) Precursors in Alleviating the High-Glucose-Induced Damage to Hepatocytes in Megalobrama amblycephala: Evidence in NAD⁺ Homeostasis, Sirt1/3 Activation, Redox Defense, Inflammatory Response, Apoptosis, and Glucose Metabolism

    Antioxidants (Basel, Switzerland)

  8. Nicotinamide riboside decreases apoptosis in human cells (co-treatment with H2O2).

    “HTM cells treated with both NR and H2O2, exhibited a reduced rate of apoptosis and generation of ROS.”

    Cellsco-treatment with H2O2

    The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells

    Translational vision science & technology

  9. Nicotinamide riboside decreases apoptosis in mice after myocardial ischemia-reperfusion injury.

    “It reduced cardiomyocyte apoptosis both in vivo and in vitro”

    Animalsafter myocardial ischemia-reperfusion injuryheart

    Nicotinamide Riboside-Driven Modulation of SIRT3/mtROS/JNK Signaling Pathways Alleviates Myocardial Ischemia-Reperfusion Injury

    International journal of medical sciences

  10. Nicotinamide riboside decreases apoptosis in Bnc1-knockdown spermatogonia.

    “Administration of nicotinamide riboside or metformin reversed mitochondrial dysfunction and inhibited apoptosis in Bnc1-knockdown spermatogonia”

    Cellsin Bnc1-knockdown spermatogoniaspermatogonia

    BNC1 deficiency induces mitochondrial dysfunction-triggered spermatogonia apoptosis through the CREB/SIRT1/FOXO3 pathway: the therapeutic potential of nicotinamide riboside and metformin†

    Biology of reproduction

All 15

More on Apoptosis

SIRT1

upin cells3upin mice3upin human cells2downin mice2+2

12 studies
  1. Nicotinamide riboside decreases SIRT1 in mice.

    “the downregulation of Sirt1, Sirt3, and Parp1”

    Animalstumor

    Dose-Dependent Angiogenic Effects of Intravenous Nicotinamide Riboside in Mice with a Lewis Lung Carcinoma Model

    Bulletin of experimental biology and medicine

  2. Nicotinamide riboside increases SIRT1 in rats under chronic variable stress (p < 0.001).

    “NR supplementation effectively corrected these biochemical imbalances and upregulated hepatic markers, including PPARγ, SIRT1, GLUT2, IRS1, and FASN (p < 0.001)”

    Animalsunder chronic variable stresslivermales

    Modulation of SIRT1/PPARγ pathways and tight junction proteins by nicotinamide riboside under chronic variable stress

    Journal of physiology and biochemistry

  3. Nicotinamide riboside increases SIRT1 in HK-2 cells.

    “NR promoted SIRT1 expression in vitro”

    Cellsin HK-2 cells

    Nicotinamide riboside alleviates sepsis-induced acute kidney injury by suppressing ferroptosis

    Journal of molecular medicine (Berlin, Germany)

  4. Nicotinamide riboside activates SIRT1 in cells.

    “NR activated SIRT1”

    Cellsintestinal epithelial cells

    Nicotinamide riboside attenuates radiation-induced intestinal injury by suppressing gasdermin E-mediated pyroptosis in intestinal epithelial cells

    Journal of translational medicine

  5. Nicotinamide riboside decreases SIRT1 in mice (Apoe knockout mice on high-cholesterol diet).

    “In liver lysates, SIRT1 and lipoprotein receptors were decreased and CD38 increased in NR++”

    AnimalsApoe knockout mice on high-cholesterol dietliverNR++ (high dose)12 weeksmales

    NAD⁺ boosting increases atherosclerotic plaques and inflammation in Apoe knockout mice

    Atherosclerosis

  6. Nicotinamide riboside increases SIRT1 in cells.

    “NR treatment upregulated Silent information regulator 1 (SirT1) expression.”

    Cells

    Effect of Nicotinamide Riboside Against the Exhaustion of CD8⁺ T Cells via Alleviating Mitochondrial Dysfunction

    Nutrients

  7. Nicotinamide riboside increases SIRT1 in cells (glutamate-induced decrease in SIRT1 protein expression).

    “NR also restored the decreased protein expression of sirtuin 1 (SIRT1) and peroxisome proliferator-activated receptor-gamma coactivator (PGC1α) induced by glutamate.”

    Cellsglutamate-induced decrease in SIRT1 protein expression

    The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model

    Experimental eye research

  8. Nicotinamide riboside increases SIRT1 in mice given nicotine plus Coca-Cola.

    “NR reduced oxidative stress and prevented mitochondrial damage by restoring protein levels of Sirtuin1 (Sirt1)”

    Animalsin mice given nicotine plus Coca-Colaliver10 weeks

    Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR)

    Frontiers in endocrinology

  9. Nicotinamide riboside activates SIRT1 in mouse cells (H9c2 cells; via NAD+ upregulation).

    “NR activated sirt 1 via the upregulation of nicotinamide adenine dinucleotide (NAD+)”

    CellsH9c2 cells; via NAD+ upregulation

    Nicotinamide ribose ameliorates myocardial ischemia/reperfusion injury by regulating autophagy and regulating oxidative stress

    Experimental and therapeutic medicine

  10. Nicotinamide riboside activates SIRT1 in mice (ethanol exposure).

    “NR supplementation activated SirT1 activity”

    Animalsethanol exposure

    NAD Supplement Alleviates Intestinal Barrier Injury Induced by Ethanol Via Protecting Epithelial Mitochondrial Function

    Nutrients

All 12

More on SIRT1

Cognitive function

no changein humans5upin humans2upin mice2no changein mice1+1

11 studies
  1. Nicotinamide riboside showed no clear effect on cognitive function in humans (randomized, placebo-controlled).

    “There were no improvements in cognitive function (primary outcome), total CBF, or blood pressure (secondary outcomes).”

    Human trialrandomized, placebo-controlled12 weeksn = 42

    Nicotinamide riboside did not improve cognition in a 12-week trial

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Nicotinamide riboside showed no clear effect on cognitive function in humans.

    “Cognitive function did not significantly improve”

    Human trial500 mg b.i.d.12-week

    A phase‐II randomized controlled pilot and feasibility study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment

    AAIC 2025 abstract

  3. Nicotinamide riboside showed no clear effect on cognitive function in humans (between-group comparison with placebo lead-in) (p-values = 0.47-0.74).

    “No significant between-group differences were observed for cognitive outcomes (ECog, RBANS, TMT-B; p-values = 0.47-0.74).”

    Human trialbetween-group comparison with placebo lead-in2000 mg/day

    Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

    EClinicalMedicine

  4. Nicotinamide riboside showed no clear effect on cognitive function in humans (β = 0.08, 95% CI: −0.16 to 0.33, p = 0.49).

    “Our findings indicate that NR supplementation did not significantly alter cognitive function compared to placebo.”

    Human trial24 weeksn = 61

    Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

    EClinicalMedicine

  5. Nicotinamide riboside improves cognitive function in humans across multiple cognitive domains.

    “cognitive enhancement across multiple domains postsupplementation”

    Human trialacross multiple cognitive domains4 weeksn = 8

    Effects of NAD⁺ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial

    The Journal of pharmacology and experimental therapeutics

  6. Nicotinamide riboside showed no clear effect on cognitive function in humans.

    “As for the primary analysis (between‐group comparison during the first 8 weeks), there were no differences in the RBANS total scaled score (p = 0.55), nor for the five subdomains.”

    Human trialtwo consecutive 8-week treatment periodsn = 46

    Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment

    Alzheimer's & dementia (New York, N. Y.)

  7. Nicotinamide riboside showed no clear effect on cognitive function in humans.

    “MoCA and other neurocognitive and psychometric metrics remained stable throughout the study.”

    Human trial1 g/day10 weeks

    A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

    GeroScience

  8. Nicotinamide riboside improves cognitive function in APP/PS1 mice.

    “NR treatment restored mitochondrial integrity, suppressed cGAS-STING signaling, and reduced neuroinflammation, improving vascular function and cognition.”

    Animalsin APP/PS1 mice

    Endothelial NAD⁺ depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  9. Nicotinamide riboside improves cognitive function in mice (aged mice compared with untreated aged controls).

    “NR supplementation improved or prevented the decline in nest-building ability, Y-maze spontaneous alternation, and novel object recognition”

    Animalsaged mice compared with untreated aged controls400 mg/kg body weight8 weeksmales

    Nicotinamide riboside supplementation restores microglial health and improves cognition in aged male mice

    GeroScience

  10. Nicotinamide riboside showed no clear effect on cognitive function in mice under daily physiological stress.

    “while not affecting cognitive function”

    Animalsunder daily physiological stress6 weeks

    Nicotinamide riboside treatment enhances stress sensitivity and modulates hematological dynamics in aged mice

    GeroScience

All 12

Cellular senescence

downin human cells4downin mice3

7 studies
  1. Nicotinamide riboside decreases cellular senescence in mice.

    “In aged male mice, two months of NR or NRH treatment suppressed senescence markers, improved diastolic function, and reduced hypertrophy and fibrosis.”

    Animalsheart2 monthsmales

    Two compounds improve heart relaxation in aged male mice

    Cardiovascular research

  2. Nicotinamide riboside decreases cellular senescence in WRN knockout MSCs and Werner syndrome patient fibroblasts compared to controls.

    “NAD+ augmentation, via supplementation with nicotinamide riboside, reduces senescence”

    Cellsin WRN knockout MSCs and Werner syndrome patient fibroblasts compared to controlssupplementation

    Decreased mitochondrial NAD+ in WRN deficient cells links to dysfunctional proliferation

    Aging

  3. Nicotinamide riboside decreases cellular senescence in human cells (DNA damage-induced).

    “Both UA and NR were shown to reduce DNA damage-induced cellular senescence.”

    CellsDNA damage-induced

    Urolithin A and nicotinamide riboside differentially regulate innate immune defenses and metabolism in human microglial cells

    Frontiers in aging neuroscience

  4. Nicotinamide riboside decreases cellular senescence in mice after 6.0 Gy γ-ray total body irradiation.

    “Our results demonstrate that NR can significantly mitigate radiation-induced intestinal senescence.”

    Animalsafter 6.0 Gy γ-ray total body irradiationintestine400 mg/kg/d21 daysmales

    Nicotinamide riboside alleviates ionizing radiation-induced intestinal senescence by alleviating oxidative damage and regulating intestinal metabolism

    Journal of advanced research

  5. Nicotinamide riboside decreases cellular senescence in human cells.

    “NR enhanced the viability and retarded senescence in hDPSCs with higher NAD+/NADH levels.”

    Cells

    Nicotinamide Riboside Modulates HIF-1 Signaling to Maintain and Enhance Odontoblastic Differentiation in Human Dental Pulp Stem Cells

    Stem cells (Dayton, Ohio)

  6. Nicotinamide riboside decreases cellular senescence in mice after 6 Gy total body irradiation.

    “Nicotinamide riboside treatment reversed aging spleen phenotypes by inhibiting cellular senescence”

    Animalsafter 6 Gy total body irradiationspleen

    Nicotinamide riboside intervention alleviates hematopoietic system injury of ionizing radiation-induced premature aging mice

    Aging cell

  7. Nicotinamide riboside decreases cellular senescence in human cells.

    “both MET and NR attenuate senescence phenotypes in human stem cells in vitro”

    Cellshuman mesenchymal stem cells

    A comparative study of metformin and nicotinamide riboside in alleviating tissue aging in rats

    Life medicine

More on Cellular senescence

Reactive oxygen species

downin human cells3downin mouse cells3downin mice1

7 studies
  1. Nicotinamide riboside decreases reactive oxygen species in streptozotocin-induced diabetic mice.

    “NR supplementation reduced ROS levels in oocytes from diabetic mice”

    Animalsin streptozotocin-induced diabetic miceoocyte400 mg/kg/day14 daysfemales

    Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality

    Reproduction (Cambridge, England)

  2. Nicotinamide riboside decreases reactive oxygen species in mouse cells (postovulatory aging model).

    “including reduced ROS accumulation, improved mitochondrial function, and corrected mis-localization of cortical granules”

    Cellspostovulatory aging modeloocyte200 μM24 hfemales

    The NAD⁺ precursor nicotinamide riboside protects against postovulatory aging in vitro

    Journal of assisted reproduction and genetics

  3. Nicotinamide riboside decreases reactive oxygen species in mouse cells (H9c2 cells).

    “In H9c2 cells, NR pretreatment reduced the levels of lactate dehydrogenase, CK-MB, malondialdehyde, superoxide dismutase and ROS”

    CellsH9c2 cells

    Nicotinamide ribose ameliorates myocardial ischemia/reperfusion injury by regulating autophagy and regulating oxidative stress

    Experimental and therapeutic medicine

  4. Nicotinamide riboside decreases reactive oxygen species in human cells (co-treatment with H2O2).

    “HTM cells treated with both NR and H2O2, exhibited a reduced rate of apoptosis and generation of ROS.”

    Cellsco-treatment with H2O2

    The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells

    Translational vision science & technology

  5. Nicotinamide riboside decreases reactive oxygen species in human cells.

    “NR administration increases sqstm1 and reduces reactive oxygen species (ROS) levels.”

    Cells

    Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects

    Cell reports. Medicine

  6. Nicotinamide riboside decreases reactive oxygen species in human cells.

    “treatment with NR leads to a reduction in mitochondrial activity and ROS production in ASCs”

    Cells

    Nicotinamide Riboside Improves Stemness of Human Adipose-Derived Stem Cells and Inhibits Terminal Adipocyte Differentiation

    Pharmaceuticals (Basel, Switzerland)

  7. Nicotinamide riboside decreases reactive oxygen species in post-ovulatory oocytes.

    “treatment with NR decreased ROS levels”

    Cellsin post-ovulatory oocytes

    Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline

    Reproduction (Cambridge, England)

More on Reactive oxygen species

Mitochondrial function

upin mice3upin cells2upin mouse cells1

6 studies
  1. Nicotinamide riboside improves mitochondrial function in cells (metabolically compromised).

    “improving mitochondrial function in metabolically compromised hematopoietic stem cells”

    Cellsmetabolically compromisedhematopoietic stem cell

    Nicotinamide Riboside for Mitochondrial Rescue in Residual HSCs

    Zenodo (CERN European Organization for Nuclear Research)Preprint

  2. Nicotinamide riboside improves mitochondrial function in mouse cells (postovulatory aging model).

    “including reduced ROS accumulation, improved mitochondrial function, and corrected mis-localization of cortical granules”

    Cellspostovulatory aging modeloocyte200 μM24 hfemales

    The NAD⁺ precursor nicotinamide riboside protects against postovulatory aging in vitro

    Journal of assisted reproduction and genetics

  3. Nicotinamide riboside improves mitochondrial function in TCM-induced and OVA(257−264) peptide-induced exhaustion models.

    “NR supplementation effectively inhibited CD8+ T cell exhaustion and preserved mitochondrial function in both models.”

    Cellsin TCM-induced and OVA(257−264) peptide-induced exhaustion models

    Effect of Nicotinamide Riboside Against the Exhaustion of CD8⁺ T Cells via Alleviating Mitochondrial Dysfunction

    Nutrients

  4. Nicotinamide riboside improves mitochondrial function in mice (pressure overload-induced cardiac dysfunction).

    “nicotinamide riboside chloride improved mitochondrial function and blunted heart failure progression”

    Animalspressure overload-induced cardiac dysfunctionnicotinamide riboside chlorideheart

    Raising NAD⁺ Level Stimulates Short-Chain Dehydrogenase/Reductase Proteins to Alleviate Heart Failure Independent of Mitochondrial Protein Deacetylation

    Circulation

  5. Nicotinamide riboside improves mitochondrial function in mice (experimental colitis).

    “Treatment of mice undergoing experimental colitis with an NAD+ precursor reduced the severity of colitis, restored mitochondrial function, and increased active PGC1α levels”

    Animalsexperimental colitisintestinal epithelium

    Epithelial NAD⁺ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation

    Frontiers in immunology

  6. Nicotinamide riboside improves mitochondrial function in HFD-fed mice and PA-treated myotubes.

    “thereby improving mitochondrial function and alleviating oxidative stress”

    Animalsin HFD-fed mice and PA-treated myotubesskeletal musclemales

    Improving Mitochondrial Function in Skeletal Muscle Contributes to the Amelioration of Insulin Resistance by Nicotinamide Riboside

    International journal of molecular sciences

More on Mitochondrial function

Autophagy

upin human cells1downin mouse cells1upin mouse cells1upin rats1

4 studies
  1. Nicotinamide riboside increases autophagy in human cells (oxygen-glucose deprivation/reperfusion).

    “NR supplementation increased intracellular NAD+ levels and enhanced autophagic activity in OGD/R-treated HUVECs”

    Cellsoxygen-glucose deprivation/reperfusionHUVEC

    Nicotinamide riboside promotes skin flap survival by enhancing autophagy associated with the NAD⁺/SIRT1-FOXO1 signaling axis

    Archives of pharmacal research

  2. Nicotinamide riboside increases autophagy in chronic cerebral hypoperfusion rats, where CCH impaired flux.

    “NR may maintain mitochondrial structural integrity and exert a protective role by attenuating mitochondrial fission and impaired autophagy flux caused by CCH.”

    Animalsin chronic cerebral hypoperfusion rats, where CCH impaired flux400 mg/kg daily3 months

    Nicotinamide riboside alleviates brain dysfunction induced by chronic cerebral hypoperfusion via protecting mitochondria

    Biochemical pharmacology

  3. Nicotinamide riboside inhibits autophagy in mouse cells (H9c2 cells).

    “the results indicated NR activated sirt 1 via the upregulation of nicotinamide adenine dinucleotide (NAD+) and protected the cells against autophagy”

    CellsH9c2 cells

    Nicotinamide ribose ameliorates myocardial ischemia/reperfusion injury by regulating autophagy and regulating oxidative stress

    Experimental and therapeutic medicine

  4. Nicotinamide riboside increases autophagy in Rev1-/- MEFs.

    “Autophagy decreases in Rev1-/- mouse embryonic fibroblasts (MEFs) and can be restored by supplementing the NAD+ precursor nicotinamide riboside (NR).”

    Cellsin Rev1-/- MEFs

    Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD⁺ precursor nicotinamide riboside

    Heliyon

More on Autophagy

Blood NAD+ concentration

upin humans4

4 studies
  1. Nicotinamide riboside increases blood NAD+ concentration in humans (twofold).

    “Blood NAD+ increased twofold in the NR group.”

    Human trialblood12 weeksn = 42

    Nicotinamide riboside did not improve cognition in a 12-week trial

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Nicotinamide riboside increases blood NAD+ concentration in humans (measured by dried blood spot analysis) (peak +20.7% relative to baseline).

    “NR IV appeared to promote the most robust increases in NAD+ concentration as measured by dried blood spot analyses, with peak NAD+ levels increasing by 20.7% relative to baseline”

    Human trialmeasured by dried blood spot analysisintravenous500 mg

    Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults

    medRxivPreprint

  3. Nicotinamide riboside increases blood NAD+ concentration in humans (NR versus placebo) (up to 5-fold increase).

    “NR greatly augmented the blood NAD metabolome with up to 5-fold increase in blood NAD+ levels.”

    Human trialNR versus placebowhole blood1500 mg twice dailyfour weeksn = 10

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease

    Nature communications

  4. Nicotinamide riboside increases blood NAD+ concentration in humans (dose escalation to 1 g/day) (2.6-fold increase (95% CI 17.77 to 43.49)).

    “The target NR dose was safely achieved as evidenced by a 2.6-fold increase in blood NAD+ in the NR group”

    Human trialdose escalation to 1 g/dayblood1 g/day10 weeks

    A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

    GeroScience

More on Blood NAD+ concentration

Adverse events

no changein humans4

4 studies
  1. Nicotinamide riboside showed no clear effect on adverse events in humans (bolus injections).

    “Both NR and NAD+ injections were well-tolerated, as no participants withdrew from discomfort or other injection-related concerns, nor were any reported severe or unexpected adverse events attributable to the test materials.”

    Human trialbolus injectionsthree consecutive daysn = 45

    Preliminary Safety Analysis of Two Pilot Clinical Trials Involving Injections of Niagen®, Nicotinamide Riboside Chloride

    medRxivPreprint

  2. Nicotinamide riboside showed no clear effect on adverse events in humans (NR vs placebo treatment phases).

    “NR supplementation was safe and well tolerated with no differences in adverse events reported between NR and PBO treatment phases.”

    Human trialNR vs placebo treatment phases1 g/day8 weeks

    Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment

    Alzheimer's & dementia (New York, N. Y.)

  3. Nicotinamide riboside showed no clear effect on adverse events in humans.

    “All AEs were graded as mild, and there was no significant difference in the frequency of adverse events between both groups.”

    Human trial4 weeksn = 20

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease

    Nature communications

  4. Nicotinamide riboside showed no clear effect on adverse events in humans.

    “with no between-group difference in adverse event reporting”

    Human trial1 g/day10 weeks

    A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment

    GeroScience

NAD+ metabolism

upin cells1upin humans1upin pigs1

3 studies
  1. Nicotinamide riboside improves NAD+ metabolism in BMI-discordant monozygotic twins.

    “NR improved systemic NAD+ metabolism, muscle mitochondrial number, myoblast differentiation, and gut microbiota composition in both cotwins.”

    Human trialin BMI-discordant monozygotic twins250 to 1000 mg/day5 monthsn = 20

    Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study

    Science advances

  2. Nicotinamide riboside increases NAD+ metabolism in cells.

    “Nicotinamide riboside enhances NAD+ biosynthesis”

    Cells

    Nicotinamide Riboside for Mitochondrial Rescue in Residual HSCs

    Zenodo (CERN European Organization for Nuclear Research)Preprint

  3. Nicotinamide riboside increases NAD+ metabolism in pigs under heat stress.

    “Supplementation with NR effectively restored testicular NAD+ metabolism.”

    Animalsunder heat stresstestismales

    Nicotinamide Riboside Supplementation Alleviates Heat Stress-Induced Testicular Damage and Improves Semen Quality in Boars

    Molecular nutrition & food research

More on NAD+ metabolism

Bioenergetic Health Index

upin humans2

2 studies
  1. Nicotinamide riboside increases Bioenergetic Health Index in humans (compared with placebo, in monocytes) (estimated difference 0.29 (95% CI 0.06 to 0.53)).

    “NR, but not CoQ10, increased the Bioenergetic Health Index (estimated difference, 0.29; 95% CI, 0.06 to 0.53)”

    Human trialcompared with placebo, in monocytesmonocytes1000 mg/dsix weeksn = 14

    A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

    Clinical journal of the American Society of Nephrology : CJASN

  2. Nicotinamide riboside increases Bioenergetic Health Index in monocytes compared with placebo (estimated mean difference of 0.29, 95% CI 0.06 to 0.53).

    “NR supplementation significantly increased monocyte spare respiratory capacity by an estimated mean difference of 3.52 (95% CI, 0.04 to 7.0 pmol/min per 10,000 cells, P = 0.04) and BHI, an index representing mitochondrial function by an estimated mean difference of 0.29 (95% CI, 0.06 to 0.53; P = 0.02) compared with placebo (Figure and Table”

    Human trialin monocytes compared with placebotabletsmonocytes6-week durationn = 14

    A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

    Clinical journal of the American Society of Nephrology : CJASN

  3. Nicotinamide riboside increases Bioenergetic Health Index in humans (monocytes, versus placebo, subsample of participants) (estimated difference 0.29 (95% CI 0.06 to 0.53)).

    “NR, but not CoQ10, increased the bioenergetic health index (BHI) (estimated difference, 0.29, 95% CI of 0.06 to 0.53)”

    Human trialmonocytes, versus placebo, subsample of participantsmonocytes1000 mg/daysix weeksn = 14

    Randomized Crossover Clinical Trial of Nicotinamide Riboside and Coenzyme Q10 on Metabolic Health and Mitochondrial Bioenergetics in CKD

    medRxiv : the preprint server for health sciencesPreprint

More on Bioenergetic Health Index

F2-isoprostanes

downin humans2

2 studies
  1. Nicotinamide riboside decreases F2-isoprostanes in humans (compared with placebo) (estimated difference -0.16 pg/ml).

    “Both NR and CoQ10 reduced five-series F2-isoprostanes (estimated difference, −0.16 and −0.11 pg/ml, respectively; P < 0.05 for both)”

    Human trialcompared with placebo1000 mg/dsix weeksn = 25

    A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

    Clinical journal of the American Society of Nephrology : CJASN

  2. Nicotinamide riboside decreases F2-isoprostanes in humans (compared with placebo).

    “NR significantly reduced total plasma F2-isoprostane levels compared with placebo.”

    Human trialcompared with placebotabletsplasma6-week durationn = 25

    A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

    Clinical journal of the American Society of Nephrology : CJASN

  3. Nicotinamide riboside decreases F2-isoprostanes in humans (versus placebo, randomized crossover trial in moderate-to-severe CKD) (estimated difference -0.16 pg/mL).

    “Both NR and CoQ10 reduced 5 series F2-Isoprostanes (estimated difference, -0.16 and -0.11 pg/mL, respectively; P<0.05 for both).”

    Human trialversus placebo, randomized crossover trial in moderate-to-severe CKD1000 mg/daysix weeksn = 25

    Randomized Crossover Clinical Trial of Nicotinamide Riboside and Coenzyme Q10 on Metabolic Health and Mitochondrial Bioenergetics in CKD

    medRxiv : the preprint server for health sciencesPreprint

More on F2-isoprostanes

All 545

What is nicotinamide riboside linked with?

10

Studies link nicotinamide riboside with 10 measures, among them post-injection pain and muscle soreness/tightness, mortality and oxidative phosphorylation.

Post-injection pain and muscle soreness/tightness

upin humans1

1 study
  1. Nicotinamide riboside is associated with post-injection pain and muscle soreness/tightness in humans (post-injection) (44% and 41%).

    “The pooled response frequency noted “pain more than two minutes post-injection” as the most frequently described observation (44%), followed by muscle soreness/tightness (41%) and itching (31%).”

    Human trialpost-injectionthree consecutive daysn = 39

    Part 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injections

    medRxivPreprint

  2. Nicotinamide riboside is associated with post-injection pain and muscle soreness/tightness in humans (Reported more than two minutes after intramuscular or subcutaneous injection) (Pain: 44%; muscle soreness/tightness: 41%).

    “Pain and muscle soreness/tightness more than two minutes after the injection were reported by 44% and 41% of the participants, respectively”

    Human trialReported more than two minutes after intramuscular or subcutaneous injectionpharmaceutical-grade injectable NR50 or 100 mg daily3 consecutive daysn = 39

    Part 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injections

    medRxivPreprint

Mortality

upin mice1

1 study
  1. Nicotinamide riboside raises the risk of mortality in mice after spinal cord contusion.

    “NR treatment decreased survival and increased astrogliosis in SCI mice compared to the vehicle control group.”

    Reviewafter spinal cord contusion750 mg/kg28 days post-injuryfemales

    NAD⁺ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use

    Spinal cord

Oxidative phosphorylation

mixedin human cells1

1 study
  1. Nicotinamide riboside is associated with oxidative phosphorylation in POLG organoids.

    “NR treatment was associated with altered expression of genes involved in oxidative phosphorylation, NADH dehydrogenase activity, respiratory chain assembly, and synaptic pathways.”

    Cellsin POLG organoidschronic

    Brain organoids show reduced energy and signaling gene activity

    Journal of translational medicine

More on Oxidative phosphorylation

Interferon response gene expression

downin humans1

1 study
  1. Nicotinamide riboside is associated with interferon response gene expression in humans (Ataxia-Telangiectasia).

    “NAD+ augmentation was associated with suppression of interferon response genes and modulation of networks correlated with neurological improvement.”

    Human trialAtaxia-Telangiectasiaperipheral blood mononuclear cells24 months

    Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD⁺ Augmentation in Ataxia-Telangiectasia

    International journal of molecular sciences

More on Interferon response gene expression

oxidative phosphorylation co-expression modules

mixedin animals1

1 study
  1. Nicotinamide riboside is associated with oxidative phosphorylation co-expression modules (brain-area specific effects).

    “We observed brain-area specific effects of NR on co-expressed protein modules of oxidative phosphorylation, fatty acid oxidation, and neurotransmitter regulation pathways, which correlated with RSI components.”

    Animalsbrain-area specific effectsbrain

    Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner

    Neurobiology of disease

Reactive species interactome

mixedin animals1

1 study
  1. Nicotinamide riboside is associated with reactive species interactome (upon NR treatment).

    “RSI analysis yielded a complex modulation upon NR treatment.”

    Animalsupon NR treatment

    Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner

    Neurobiology of disease

More on Reactive species interactome

steroid metabolism

mixedin mice1

1 study
  1. Nicotinamide riboside is associated with steroid metabolism in mice (kidney aging).

    “Transcriptome analysis revealed that NR regulates kidney steroid metabolism in aging.”

    Animalskidney agingkidney

    Ganoderma lucidum alleviates kidney aging by modulating gut microbiota

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Glycolysis

upin mice1

1 study
  1. Nicotinamide riboside is associated with glycolysis in mice (perfusion with glucose + fatty acids).

    “was associated with activated glycolysis, without changes in TCA cycle or PPP activities”

    Animalsperfusion with glucose + fatty acidsheart

    Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside

    Basic research in cardiology

More on Glycolysis

Total MDS-UPDRS score

downin humans1

1 study
  1. Nicotinamide riboside is associated with total MDS-UPDRS score in humans (change also associated with shorter interval since the last levodopa dose).

    “NR therapy was associated with clinical improvement of total MDS-UPDRS scores.”

    Human trialchange also associated with shorter interval since the last levodopa dose1500 mg twice dailyfour weeksn = 20

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease

    Nature communications

Safety and tolerability

no changein humans1

1 study
  1. Nicotinamide riboside is associated with safety and tolerability in humans.

    “In this relatively small trial, no between-group differences were observed in treatment-emergent AEs.”

    Human trial12 weeksn = 30

    Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction

    JACC. Basic to translational science

Has nicotinamide riboside been tested in people?

37 of 75 about aging

Yes: 67 trials and 16 observational studies in people have been published, and 72 trials are registered.

Every condition in trials

40 of 75

Stopped

  • NCT03565328TerminatedHeart failure

    Slow/insufficient accrual and investigators have left the study.

  • NCT03642990TerminatedEndometrial neoplasm

    Enrollment challenges

  • NCT03685253TerminatedDiabetes mellitus

    Completed the pilot study and grant funding not obtained to continue to the main phase 2 study. The pilot study did not show a statistical significance in the primary or secondary outcome measures.

  • NCT03151707Terminated

    Lack of funding and appropriate staff

Who is developing nicotinamide riboside?

1 company: ChromaDex.

Companies

Trial sponsors

Funding

17 grants since 2017

National Institute on Aging$9.3MUS Department of Veterans AffairsNational Institute of Diabetes and Digestive and Kidney Diseases$2.6M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Nicotinamide riboside extends yeast lifespan across independent labs; human trials report increased or unchanged NAD+ and unchanged cognition. Mouse inflammation changes point both ways, with increases independently replicated. Registrations include 23 aging-related trials; across uses, 12 trials ended over a year ago without posted results or citing papers, and 14 of 51 human papers declare developer ties.

  2. Summary rewritten as its findings changed.

    As it read before

    Independent labs report longer yeast lifespan with nicotinamide riboside; a mouse study reports longer lifespan in females lacking cardiac REV-ERBs. Human studies report increased NAD+ or no change, and independent labs report increased mouse inflammation. Fifteen registered trials concern aging; 13 trials across uses have no results posted over a year after ending; 10 human papers declare ties to its developers.

  3. Summary rewritten as its findings changed.

    As it read before

    Independent labs report yeast lifespan extension and higher mouse NAD+ with nicotinamide riboside; human trials report higher NAD+, though mouse and human studies also report no change. An early Parkinson disease trial reports increased nonmotor symptom scores versus placebo. Fifteen registered trials concern aging; 13 trials across uses ended over a year ago without posted results or citing papers; human papers declare developer ties.

  4. Summary rewritten as its findings changed.

    As it read before

    Nicotinamide riboside extends yeast lifespan across independent labs; mouse studies report lifespan extension or no change. Human trials report higher NAD+ but unchanged cognition; an early Parkinson disease trial favors placebo on symptom scores. Eleven registered trials concern aging; across all uses, 13 lack posted results over a year after ending, companies sponsor 11, and company-affiliated authors contribute to 13 findings.

  5. Summary rewritten as its findings changed.

    As it read before

    One mouse preprint reports that nicotinamide riboside increases NAD+ and decreases mitochondrial reactive oxygen species and CD38 in CD8-positive T cells during T. cruzi infection, while reducing parasitemia and skeletal muscle parasite burden during acute infection.

Latest

Dec 2025: 5Jan 2026: 17Feb 2026: 12Mar 2026: 12Apr 2026: 25May 2026: 6Jun 2026: 11Jul 2026: 7Aug 2026: 6Sep 2026: 5Oct 2026: 14Nov 2026: 10130 papers in 12 months
AHA Scientific Sessions 2026 Abstract

High-fat diet triggers irregular heart rhythms in altered mice

Nearly 100% of genetically susceptible mice developed the irregular heartbeat on a high-fat diet, offering a model for studying metabolic changes.Nearly 100% of genetically susceptible mice developed the irregular heartbeat on a high-fat diet, offering a model for studying metabolic changes.

Mouse studyInterventions

See all 640 papers on nicotinamide riboside